CHMP Meeting Highlights-BASG

Austrian members of the CHMP report on meetings concerning centralised procedures: New approvals, extensions of indication, newly publish EPARs and recently started procedures.

News

CHMP Meeting Highlights November 2021

CHMP Monthly News | 15/12/2021
Up-to-date information from the November 08.11.-11.11.2021 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights November 2021 Read more
News

CHMP Meeting Highlights October 2021

CHMP Monthly News | 03/11/2021
Up-to-date information from the October 11-14 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights October 2021 Read more
News

CHMP Meeting Highlights August 2021

CHMP Monthly News | 21/10/2021
Current information from the meeting on 16-18 August 2021: special issue Ipilimumab
CHMP Meeting Highlights August 2021 Read more
News

CHMP Meeting Highlights September 2021

CHMP Monthly News | 21/10/2021
Up-to-date information from the July 19-22 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights September 2021 Read more
News

CHMP Meeting Highlights July 2021

CHMP Monthly News | 04/08/2021
Up-to-date information from the July 19-22 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights July 2021 Read more
News

CHMP Meeting Highlights June 2021

CHMP Monthly News | 07/07/2021
Up-to-date information from the June 21-24 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights June 2021 Read more
News

CHMP Meeting Highlights May 2021

CHMP Monthly News | 17/06/2021
Up-to-date information from the May 17-20 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights May 2021 Read more
Email

Further inquiry note